Interleukin-2- and neopterin-induced neopterin release from peripheral blood mononuclear cells

References

• Nichol C A, Smith G K, Duch D S. Biosynthesis and metabolism of tetrahydrobiopterin and moly-bdopterin (review). Ann Rev Biochem 1985; 54: 729–64
   PubMed Web of Science ®Google Scholar
• Fuchs D, Hansen A, Reibnegger G, Werner E R, Dierich M P, Wachter H. Neopterin as a marker for activated cell-mediated immunity (review). Immunol Today 1988; 9: 150–5
   PubMedGoogle Scholar
• Kern P, Rokos H, Dietrich M. Raised serum neopterin levels and imbalances of T-lymphocyte subsets in viral diseases, AIDS and related lymphadenopathy syndromes. Biomed Phar-macother 1984; 38: 407–11
   PubMed Web of Science ®Google Scholar
• Huber C, Fuchs D, Hausen A, Marzreiter R, Reibnegger G, Spielberger M, Wachter H. Pteri-dines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatibility complex (MCH) determinants. J Immunol 1983; 130: 1047–50
   PubMed Web of Science ®Google Scholar
• Huber C, Batchelor J R, Fuchs D. Immune response-associated production of neopterin-release from macrophages primarily under control of interferon-gamma. J Exp Med 1984; 160: 310–6
   PubMed Web of Science ®Google Scholar
• Bitterlich G, Szabo G, Werner E R, Larcher C, Fuchs D, Hausen A, Reibnegger G, Schultz T, Troppmair J, Wachter H, Dierich M P. Selective induction of mononuclear phagocytes to produce neopterin by interferons. Immunobiol 1988; 166: 228–35
   Web of Science ®Google Scholar
• Ziegler I, Schwulera U, Ellwart J. Pteridines are produced during Interleukin-2-indicated T cell proliferation and modulate transmission of this signal. Exp Cell Res 1986; 167: 531–38
   PubMed Web of Science ®Google Scholar
• Levine R A. Tetrahydrobiopterin and biogenic amine metabolism in neuropsychiatry, immunology and aging. Neuroimmunomodulation Interventions in Aging and Cancer, W Pierpaoli, N H Spector, New York 1988; Vol. 521: 129–39
   Google Scholar
• Blau N, Curtius H C. Neopterin and AIDS. Clin Chem 1988; 34: 2184–85
   PubMed Web of Science ®Google Scholar
• Kuznits R, Ludwig H, Legenstein E, Szekeresz T, Kratzik C, Hofbauer J. Neopterin as tumor marker: serum and urinary neopterin concentrations in malignant diseases. J Clin Chem Clin Biochem 1986; 24: 119–24
   PubMedGoogle Scholar
• Hausen A, Wachter H. Pteridines in the assessment of neoplasia. J Clin Chem Clin Biochem 1982; 20: 593–602
   PubMedGoogle Scholar
• Stea B, Halpern R M, Halpern B C, Smith R A. Urinary excretion levels of unconjugated pterines in cancer patients and normal individuals. Clin Chim Acta 1981; 113: 231–42
   PubMed Web of Science ®Google Scholar
• Andondonskaja-Renz B, Zeitler H. Pteridines in plasma and in cells of peripheral blood from tumor patients. Biochemical and Clinical Aspects of Pteridines, W Pfleiderer, H Wachter, H C Curtius. Walter deGruyter, New York 1984; vol. 3: 295–311
   Google Scholar
• Prior C, Fuchs D, Hausen A, Judmaier G, Reibnegger G, Werner E R, Vogel W, Wachter H. Potential of urinary neopterin excretion in differentiating chronic nonA nonB hepatitis from fatty liver. Lancet 1987; ii: 1235–7
   Google Scholar
• Fuchs D, Hausen A, Reibnegger G, Reisoige H, Schaunitzer D, Spira T, Wachter H. Urinary neopterin in the diagnosis of AIDS. Eur S Clin Microbiol 1985; 3: 70–1
   Google Scholar
• Fuchs D, Hausen M, Kofler M, Kosanowski H, Reibnegger G, Wachter H. Neopterin as an index of immune response in patients with tuberculosis. Lung 1984; 162: 337–46
   PubMed Web of Science ®Google Scholar
• Reibnegger G, Boonpucknavig V, Fuchs D, Hausen D, Schmutzhard E, Wachter H. Urinary neopterin is elevated in patients with malaria. Trans R Soc Trop Med Hyg 1984; 78: 545–6
   PubMed Web of Science ®Google Scholar
• Prior C, Bollbach R, Fuchs D, Hausen A, Judmaier G, Niederwieser D, Reibnegger G, Rotthauwe H W, Werner E R, Wachter H. Urinary neopterin, a marker of clinical activity in patients with Chron's disease. Clin Chim Acta 1986; 155: 11–22
   PubMed Web of Science ®Google Scholar
• Reibnegger G, Egg D, Fuchs D, Gunther R, Hausen A, Werner E R, Wachter H. Urinary neopterin reflects clinical activity in patients with rheumatoid arthritis. Arthritis Rheum 1986; 29: 1063–9
   PubMed Web of Science ®Google Scholar
• Margreiter R, Fuchs D, Hausen A, Huber C, Reibnegger G, Spielberg M, Wachter H. Neopterin as a new biochemical marker for diagnosis of allograft rejection. Transplantation 1983; 36: 650–3
   PubMed Web of Science ®Google Scholar
• Niederwieser D, Huber C. Gratwohl A, Bannert P, Fuchs D, Hausen A, Reibnegger G, Speck B, Wachter H. Neopterin as a new biochemical marker in the clinical monitoring of bone marrow transplant recipients. Transplantation 1984; 38: 497–500
   PubMed Web of Science ®Google Scholar
• Aulitzky W E, Tieg H, Nicderweiser D, Riccabona G, Obendorf L, Margreiter R, Pfallcr W, Huber C. Comparison of serum neopterin levels and urinary neopterin excretion in renal allograft recipients. Clin Nephrol 1988; 29: 248–52
   PubMed Web of Science ®Google Scholar
• Reibnegger G, Fuchs D, Grubauer G, Hausen A, Wachter H. Neopterin excretion during incubation period, clinical manifestation and reconvalscence of viral infection. Biochemical and Clinical Aspects of Pteridincs, W Pflciderer, H Wachter, H C Curtius. Walter de Gruyter, New York 1987; vol. 3: 433–7
   Google Scholar
• Fuchs D, Reibnegger G, Wachter H, Jaeger H, Popcscu M, Kaboth W. Neopterin levels correlating with the Walter Reed staging classification in HIV infection. Ann Intern Med 1987; 107: 512–3
   Web of Science ®Google Scholar
• Huber C, Troppmair J, Tilg H, Woloszczuk W, Niederwieser D, Robos H, Margreiter R. Assessment of endogenous interferon release by evaluation of neopterin levels: a new concept for monitoring of human allograft recipients. Transplant Proc 1985; 17: 2513–5
   Web of Science ®Google Scholar
• Woloszczuk W, Troppmair J, Leiter E, Flever R, Schwartz M, Kovarik T, Pohanka E, Margreiter R, Huber C. Relationship of y-IFN and neopterin levels during stimulation with alloantigens in vivo and in vitro. Transplant 1986; 41: 716–9
   PubMed Web of Science ®Google Scholar
• Woloszczuk W, Schwartz M, Havel M, Laczkovics A, Muller M M. Neopterin and interferon gamma serum levels in patients with heart and kidney transplants. J Clin Chem Clin Biochem 1986; 24: 729–34
   PubMedGoogle Scholar
• Zicgler I, Hamm U, Berndt J. Participation of pterins in the control of lymphocyte stimulation and lymphoblast proliferation. Cancer Res 1983; 43: 5356–9
   PubMed Web of Science ®Google Scholar
• Niederwieser D, Albert E, Fuchs D, Hausen A, Margreiter R, Reibnegger G, Schonitzer D, Troppmair J, Wachter H, Huber C. Neopterin release in human mixed lymphocyte culture: requirement of HLA-DR disparity. Immunology Lett 1985; 11: 95–9
   PubMed Web of Science ®Google Scholar
• Zieglcr I. Pteridine formation during lectin induced activation of mouse spleen lymphocytes. Biochemical and Clinical Aspects of Pteridines, W Pflciderer, H Wachter, H C Curtius. Walter de Guyter, New York 1984; vol. 3: 265–74
   Google Scholar
• HubcrCTroppmair J, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Wachter H, Margreiter R. Immune response-associated production of neopterin: release from macrophages under control of lymphokines. Transplant Proc 1984; 17: 582–5
   Web of Science ®Google Scholar
• Zieglcr I. Synthesis and y-IFN controlled release of pteridines during activation of human peripheral blood mononuclear cells. Biochem Biophys Res Com 1985; 132: 404–11
   PubMed Web of Science ®Google Scholar
• Barak M, Merzbach D, Gruener N. Neopterin measured in serum and tissue culture supernates by a competitive enzyme-linked immunosorbent assay. Clin Chem 1989; 35: 1467–71
   PubMed Web of Science ®Google Scholar
• Murray H W. Interferon y, the activated macrophage, and hose defence against microbiol challenge. Ann Intern Med 1988; 108: 595–608
   PubMed Web of Science ®Google Scholar
• Kashara T, Hooks J J, Dougherty S F, Oppenheim J J. IL-2 mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets. J Immunol 1983; 130: 1784–9
   PubMed Web of Science ®Google Scholar
• Kelly C D, Welte K, Murray H W. Antigen induced human interferon-production: differential dependence on IL-2 and its receptor. J Immunol 1987; 139: 2325–8
   PubMed Web of Science ®Google Scholar
• Reem G H, Yeh N H. IL-2 regulates expression of its receptor and synthesis of γ-IFN by human T lymphocytes. Science 1984; 225: 429–30
   PubMed Web of Science ®Google Scholar
• Vilcek J, Henriksen-Destefano J, Siegcl D D, Klion A, Robb R J, Le J. Regulation of y-IFN induction in human peripheral blood cells by exogenous and endogenously produced IL-2. J Immunol 1985; 135: 1851–6
   PubMed Web of Science ®Google Scholar
• Farrar W L, Birchenall-Sparks M C, Young H B. IL-2 induction of y-IFN in RNA synthesis. J Immunol 1986; 137: 3836–40
   PubMed Web of Science ®Google Scholar
• Rosztoczy I, Siroki O, Bcladi I. Effects of IFN-u, P and y on human IL-2 production. J Interferon Res 1986; 6: 581–9
   PubMedGoogle Scholar
• Johnson H M, Farrar W L. The role of y-IFN like lymphokine in the activation of T cells for expression of IL-2 receptors. Cell Immunol 1983; 75: 154–9
   PubMed Web of Science ®Google Scholar
• Kern P, Toy J, Dietrich M. Preliminary clinical observations with recombinant IL-2 in patients with AIDS or LAS. Blut 1985; 50: 1–6
   PubMedGoogle Scholar
• Ritter S, Henzc M, Anders F. Effect of pteridines on normal and neoplastic cell lives of Xipho-phorus. Cell Biol Int Rep 1988; 12: 431–2
   PubMedGoogle Scholar
• Barak M, Merzbach D, Gruener N. The effect of immunomodulators on PHA or γ-IFN induced release of neopterin from purified macrophages and peripheral blood mononuclear cells. Immunol Lett 1989; 21: 317–22
   PubMed Web of Science ®Google Scholar